177 related articles for article (PubMed ID: 25856578)
1. From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study.
Mpanya A; Hendrickx D; Baloji S; Lumbala C; da Luz RI; Boelaert M; Lutumba P
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003686. PubMed ID: 25856578
[TBL] [Abstract][Full Text] [Related]
2. Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo.
Mpanya A; Hendrickx D; Vuna M; Kanyinda A; Lumbala C; Tshilombo V; Mitashi P; Luboya O; Kande V; Boelaert M; Lefèvre P; Lutumba P
PLoS Negl Trop Dis; 2012 Jan; 6(1):e1467. PubMed ID: 22272367
[TBL] [Abstract][Full Text] [Related]
3. Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo.
Robays J; Lefèvre P; Lutumba P; Lubanza S; Kande Betu Ku Mesu V; Van der Stuyft P; Boelaert M
Trop Med Int Health; 2007 Feb; 12(2):290-8. PubMed ID: 17300638
[TBL] [Abstract][Full Text] [Related]
4. Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk.
Lumbala C; Simarro PP; Cecchi G; Paone M; Franco JR; Kande Betu Ku Mesu V; Makabuza J; Diarra A; Chansy S; Priotto G; Mattioli RC; Jannin JG
Int J Health Geogr; 2015 Jun; 14():20. PubMed ID: 26047813
[TBL] [Abstract][Full Text] [Related]
5. Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis: A critical appraisal of 23 years of experience in the Democratic Republic of Congo.
Kazumba LM; Kaka JT; Ngoyi DM; Tshala-Katumbay D
PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006504. PubMed ID: 29897919
[TBL] [Abstract][Full Text] [Related]
6. Health care-seeking behaviour and diagnostic delays for Human African Trypanosomiasis in the Democratic Republic of the Congo.
Hasker E; Lumbala C; Mbo F; Mpanya A; Kande V; Lutumba P; Boelaert M
Trop Med Int Health; 2011 Jul; 16(7):869-74. PubMed ID: 21447063
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes for human African Trypanosomiasis in the Democratic Republic of the Congo: analysis of routine program data from the world's largest sleeping sickness control program.
Hasker E; Mpanya A; Makabuza J; Mbo F; Lumbala C; Kumpel J; Claeys Y; Kande V; Ravinetto R; Menten J; Lutumba P; Boelaert M
Trop Med Int Health; 2012 Sep; 17(9):1127-32. PubMed ID: 22809002
[TBL] [Abstract][Full Text] [Related]
8. High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo.
Robays J; Nyamowala G; Sese C; Betu Ku Mesu Kande V; Lutumba P; Van der Veken W; Boelaert M
Emerg Infect Dis; 2008 Jun; 14(6):966-7. PubMed ID: 18507916
[TBL] [Abstract][Full Text] [Related]
9. Trypanosomiasis control, Democratic Republic of Congo, 1993-2003.
Lutumba P; Robays J; Miaka mia Bilenge C; Mesu VK; Molisho D; Declercq J; Van der Veken W; Meheus F; Jannin J; Boelaert M
Emerg Infect Dis; 2005 Sep; 11(9):1382-8. PubMed ID: 16229766
[TBL] [Abstract][Full Text] [Related]
10. In the heart of darkness: sleeping sickness in Zaire.
Ekwanzala M; Pépin J; Khonde N; Molisho S; Bruneel H; De Wals P
Lancet; 1996 Nov; 348(9039):1427-30. PubMed ID: 8937285
[TBL] [Abstract][Full Text] [Related]
11. Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo.
Pyana PP; Sere M; Kaboré J; De Meeûs T; MacLeod A; Bucheton B; Van Reet N; Büscher P; Belem AMG; Jamonneau V
Infect Genet Evol; 2015 Mar; 30():128-133. PubMed ID: 25535944
[TBL] [Abstract][Full Text] [Related]
12. Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo.
Kuemmerle A; Schmid C; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Ngolo D; Kisala M; Valverde Mordt O
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0008028. PubMed ID: 31986140
[TBL] [Abstract][Full Text] [Related]
13. Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo.
Mitashi P; Hasker E; Mbo F; Van Geertruyden JP; Kaswa M; Lumbala C; Boelaert M; Lutumba P
Trop Med Int Health; 2015 Jan; 20(1):98-105. PubMed ID: 25329353
[TBL] [Abstract][Full Text] [Related]
14. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
[TBL] [Abstract][Full Text] [Related]
15. Review of the Situation of Human African Trypanosomiasis in the Republic of Congo From the 1950s to 2020.
Bemba I; Bamou R; Lenga A; Okoko A; Awono-Ambene P; Antonio-Nkondjio C
J Med Entomol; 2022 Mar; 59(2):421-429. PubMed ID: 35137146
[TBL] [Abstract][Full Text] [Related]
16. Clinical trials as disease control? The political economy of sleeping sickness in the Democratic Republic of the Congo (1996-2016).
Falisse JB; Mpanya A
Soc Sci Med; 2022 Apr; 299():114882. PubMed ID: 35299059
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiological, clinical and sociodemographic characteristics of human African trypanosomiasis (HAT) in and around Kinshasa, Democratic Republic of Congo].
Tshimungu K; Okenge LN; Mukeba JN; Kande VB; De Mol P
Sante; 2009; 19(2):73-80. PubMed ID: 20031514
[TBL] [Abstract][Full Text] [Related]
18. [Re-emergence of human African trypanosomiasis in Kinshasa, Democratic Republic of Congo (DRC)].
Tshimungu K; Okenge LN; Mukeba JN; de Mol P
Med Mal Infect; 2010 Aug; 40(8):462-7. PubMed ID: 20079989
[TBL] [Abstract][Full Text] [Related]
19. Human African trypanosomiasis in a rural community, Democratic Republic of Congo.
Lutumba P; Makieya E; Shaw A; Meheus F; Boelaert M
Emerg Infect Dis; 2007 Feb; 13(2):248-54. PubMed ID: 17479887
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of a dried blood spot strategy for serological screening and surveillance to monitor elimination of Human African Trypanosomiasis in the Democratic Republic of the Congo.
Inocencio da Luz R; Phanzu DM; Kiabanzawoko ON; Miaka E; Verlé P; De Weggheleire A; Büscher P; Hasker E; Boelaert M
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009407. PubMed ID: 34115754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
